ACET Projected Dividend Yield
Adicet Bio Inc ( NASDAQ : ACET )Adicet Bio, Inc. is a clinical stage biotechnology company. Co. is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma (NHL). 21 YEAR PERFORMANCE RESULTS |
ACET Dividend History Detail ACET Dividend News ACET Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |